TRIMTECH Therapeutics raises $44.1M Seed (United Kingdom, Jun 2026)

$44.1M
€41 million
Generated social card
TRIMTECH Therapeutics social card
Headline

Cambridge’s TRIMTECH Therapeutics brings Seed round to €41 million for neurodegenerative disease work - EU-Startups

About

TRIMTECH Therapeutics is focused on developing innovative treatments for neurodegenerative diseases. The company aims to address significant unmet medical needs in this area, making it a notable player in the health sector. The recent funding round will support their research and development efforts.

Article summary

Cambridge’s TRIMTECH Therapeutics brings Seed round to €41 million for neurodegenerative disease work  EU-Startups

Investors
Related rounds
Jun 23, 2026Astral Systems$27.6MSeries AUnited Kingdom
Jun 22, 2026Isometric$36.4MUnited Kingdom
Jun 18, 2026NHS AI agent startup$12KUnited Kingdom
Jun 18, 2026Space Forge$12KGrantUnited Kingdom
TRIMTECH Therapeutics raises $44.1M Seed (United Kingdom, June 2026) | Datapile